Filtros de búsqueda

Lista de obras de Andrew M Evens

13th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI) Bethesda, MD, USA. 7-8 November 2011. Abstracts

article

A 3-Arm Randomized Phase II Study of Bendamustine/Rituximab with Bortezomib Induction or Lenalidomide Continuation in Untreated Follicular Lymphoma: ECOG-ACRIN E2408

artículo científico publicado en 2020

A Circulating microRNA Signature Predicts Age-Based Development of Lymphoma

artículo científico publicado en 2017

A Clinico-Pathologic Correlation. Burkitt's lymphoma)

artículo científico publicado en 2015

A Phase I/II Multicenter, Open-Label Study of the Oral Histone Deacetylase Inhibitor Abexinostat in Relapsed/Refractory Lymphoma

artículo científico publicado en 2015

A multicenter phase II study incorporating high-dose rituximab and liposomal doxorubicin into the CODOX-M/IVAC regimen for untreated Burkitt's lymphoma.

artículo científico publicado en 2013

A multicentre study of primary breast diffuse large B-cell lymphoma in the rituximab era.

artículo científico publicado en 2014

A phase I/II trial of bortezomib combined concurrently with gemcitabine for relapsed or refractory DLBCL and peripheral T-cell lymphomas

artículo científico publicado en 2013

A phase II clinical trial of intensive chemotherapy followed by consolidative stem cell transplant: long-term follow-up in newly diagnosed mantle cell lymphoma

artículo científico publicado en 2007

A phase II study of cyclophosphamide, etoposide, vincristine and prednisone (CEOP) Alternating with Pralatrexate (P) as front line therapy for patients with peripheral T-cell lymphoma (PTCL): final results from the T- cell consortium trial

artículo científico publicado en 2015

A retrospective multicenter analysis of elderly Hodgkin lymphoma: outcomes and prognostic factors in the modern era.

artículo científico publicado en 2011

A systematic review of therapeutic regimens for older patients with newly diagnosed Hodgkin lymphoma

scientific article published on 26 February 2020

All trans retinoic acid nanodisks enhance retinoic acid receptor mediated apoptosis and cell cycle arrest in mantle cell lymphoma

artículo científico publicado en 2010

Allogeneic Hematopoietic Cell Transplantation as Curative Therapy for Patients with Non-Hodgkin Lymphoma: Increasingly Successful Application to Older Patients

artículo científico publicado en 2016

An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas

artículo científico publicado en 2012

Analysis of very elderly (≥80 years) non-hodgkin lymphoma: impact of functional status and co-morbidities on outcome.

artículo científico publicado en 2011

Assessing the risk of cardiac toxicity after contemporary treatment for Hodgkin lymphoma: a systematic review.

artículo científico publicado en 2017

Author Correction: Role of hypoxia in Diffuse Large B-cell Lymphoma: Metabolic repression and selective translation of HK2 facilitates development of DLBCL.

artículo científico publicado en 2018

Bortezomib may be safely combined with Y-90-ibritumomab tiuxetan in patients with relapsed/refractory follicular non-Hodgkin lymphoma: a phase I trial of combined induction therapy and bortezomib consolidation

artículo científico publicado en 2012

Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole

artículo científico publicado en 2007

Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy

artículo científico publicado en 2007

Burkitt's and Burkitt-like lymphoma.

artículo científico publicado en 2002

C-MYC-positive relapsed and refractory, diffuse large B-cell lymphoma: Impact of additional "hits" and outcomes with subsequent therapy

artículo científico publicado en 2017

CD23+ mantle cell lymphoma: a clinical pathologic entity associated with superior outcome compared with CD23- disease

artículo científico publicado en 2008

Can the stem cell mobilization technique influence CD34+ cell collection efficiency of leukapheresis procedures in patients with hematologic malignancies?

artículo científico publicado en 2005

Chemotherapeutic advancements in peripheral T-cell lymphoma.

artículo científico publicado en 2013

Clinical characteristics of erythropoietin-associated pure red cell aplasia.

artículo científico publicado en 2005

Clinical, morphologic, immunophenotypic, and molecular cytogenetic assessment of CD4-/CD8-γδ T-cell large granular lymphocytic leukemia

artículo científico publicado en 2011

Clinicopathologic consensus study of gray zone lymphoma with features intermediate between DLBCL and classical HL

artículo científico publicado en 2017

Combinatorial ixazomib and belinostat therapy induces NFE2L2-dependent apoptosis in Hodgkin and T-cell lymphoma

artículo científico publicado en 2019

Comparative analysis of flow cytometric techniques in assessment of ZAP-70 expression in relation to IgVH mutational status in chronic lymphocytic leukemia

scientific article published on 01 February 2007

Comparative oncology DNA sequencing of canine T cell lymphoma via human hotspot panel.

artículo científico publicado en 2018

Continuum of Care for Hodgkin Lymphoma: Impact of Modern Therapy on Postacute Morbidity and Mortality

artículo científico publicado en 2020

Correction: Comparative oncology DNA sequencing of canine T cell lymphoma via human hotspot panel

artículo científico publicado en 2018

Curing Hodgkin's lymphoma: quantity and quality.

artículo científico publicado en 2009

Current Treatment Options for Older Patients with Hodgkin Lymphoma

scientific article published on 23 April 2020

Current therapeutic strategies and new treatment paradigms for follicular lymphoma

artículo científico

De novo CD5+ diffuse large B-cell lymphoma: Adverse outcomes with and without stem cell transplantation in a large, multicenter, rituximab treated cohort

artículo científico publicado en 2016

Deep sequencing of the small RNA transcriptome of normal and malignant human B cells identifies hundreds of novel microRNAs

artículo científico publicado en 2010

Dietary factors and risk of t(14;18)-defined subgroups of non-Hodgkin lymphoma

artículo científico publicado en 2008

Dietary intake of fruit and vegetables and risk of non-Hodgkin lymphoma.

artículo científico publicado en 2011

Diffuse large B-cell lymphoma associated with the use of biologic and other investigational agents: the importance of long-term post-marketing safety surveillance

scientific article published on 01 January 2011

Diffuse large B-cell lymphoma with primary treatment failure: Ultra-high risk features and benchmarking for experimental therapies.

artículo científico publicado en 2016

Does Q fever contribute to pathogenesis of non-Hodgkin lymphoma?

artículo científico publicado en 2018

Dynamic Analysis of Human Natural Killer Cell Response at Single-Cell Resolution in B-Cell Non-Hodgkin Lymphoma

artículo científico publicado en 2017

Early posttransplant lymphoproliferative disease: clinicopathologic features and correlation with mTOR signaling pathway activation.

artículo científico publicado en 2012

Early-stage Hodgkin lymphoma in the modern era: simulation modelling to delineate long-term patient outcomes.

artículo científico publicado en 2018

Efficacy of salvage chemotherapy in diffuse large B cell lymphoma with primary treatment failure according to putative cell of origin

artículo científico publicado en 2018

Epoetin-induced pure red-cell aplasia (PRCA): preliminary results from the research on adverse drug events and reports (RADAR) group.

artículo científico publicado en 2005

Evaluation of Serious Adverse Drug Reactions

artículo científico publicado en 2007

Expression of CD25 independently predicts early treatment failure of acute myeloid leukaemia (AML).

artículo científico publicado en 2012

Expression of the candidate MCT-1 oncogene in B- and T-cell lymphoid malignancies.

artículo científico publicado en 2003

F-18 FDG-PET predicts outcomes for patients receiving total lymphoid irradiation and autologous blood stem-cell transplantation for relapsed and refractory Hodgkin lymphoma

artículo científico publicado en 2014

FDG-PET imaging for Hodgkin lymphoma: current use and future applications

artículo científico publicado en 2014

Fatty Acid Synthase induced S6Kinase facilitates USP11-eIF4B complex formation for sustained oncogenic translation in DLBCL.

artículo científico publicado en 2018

First-line treatment in older patients with Hodgkin lymphoma: a Surveillance, Epidemiology, and End Results (SEER)-Medicare population-based study

artículo científico publicado en 2020

Five-year follow-up of SWOG S0816: limitations and values of a PET-adapted approach with stage III/IV Hodgkin lymphoma

scientific article published on 01 October 2019

Frontline bortezomib and rituximab for the treatment of newly diagnosed high tumour burden indolent non-Hodgkin lymphoma: a multicentre phase II study

artículo científico publicado en 2014

G-CSF is not necessary to maintain over 99% dose-intensity with ABVD in the treatment of Hodgkin lymphoma: low toxicity and excellent outcomes in a 10-year analysis.

artículo científico publicado en 2007

Gemtuzumab ozogamicin-associated sinusoidal obstructive syndrome (SOS): an overview from the research on adverse drug events and reports (RADAR) project

artículo científico publicado en 2006

Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma

artículo científico publicado en 2017

Genetic heterogeneity of diffuse large B-cell lymphoma

artículo científico publicado en 2013

Glutathione depletion enhances arsenic trioxide-induced apoptosis in lymphoma cells through mitochondrial-independent mechanisms

artículo científico publicado en 2010

Granulocyte-colony stimulating factor administration to healthy individuals and persons with chronic neutropenia or cancer: an overview of safety considerations from the Research on Adverse Drug Events and Reports project.

artículo científico publicado en 2007

Gray Zone Lymphoma: Current Diagnosis and Treatment Options

artículo científico publicado en 2016

Gray zone lymphoma with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma: characteristics, outcomes, and prognostication among a large multicenter cohort.

artículo científico publicado en 2015

Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project

artículo científico publicado en 2006

Health-related quality of life in Hodgkin lymphoma: a systematic review

artículo científico publicado en 2016

Hematologic Malignancies in Pregnancy: Management Guidelines From an International Consensus Meeting

artículo científico publicado en 2015

Hodgkin Lymphoma: Current Status and Clinical Trial Recommendations.

artículo científico publicado en 2016

Hodgkin lymphoma in older patients: an uncommon disease in need of study

artículo científico publicado en 2008

Hodgkin lymphoma post-transplant lymphoproliferative disorder: A comparative analysis of clinical characteristics, prognosis, and survival.

artículo científico publicado en 2016

How I manage patients with grey zone lymphoma.

artículo científico publicado en 2016

How can outcomes be improved for older patients with Hodgkin lymphoma?

artículo científico publicado en 2013

Hypoxia inducible factor-alpha activation in lymphoma and relationship to the thioredoxin family

artículo científico publicado en 2008

Hypoxia-inducible factor-1 {alpha} expression predicts superior survival in patients with diffuse large B-cell lymphoma treated with R-CHOP.

artículo científico publicado en 2010

Identification of Circulating Serum Multi-MicroRNA Signatures in Human DLBCL Models

scientific article published on 20 November 2019

Imexon-induced apoptosis in multiple myeloma tumor cells is caspase-8 dependent.

artículo científico publicado en 2004

Immunosuppressive therapy of LGL leukemia: prospective multicenter phase II study by the Eastern Cooperative Oncology Group (E5998)

artículo científico publicado en 2014

Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis.

artículo científico publicado en 2014

Important new developments in Hodgkin Lymphoma

artículo científico publicado en 2019

Improving outcomes in PTLD

artículo científico publicado el 1 de septiembre de 2010

Inhibition of bromodomain proteins for the treatment of human diffuse large B-cell lymphoma.

artículo científico publicado en 2014

Interaction kinetics with transcriptomic and secretory responses of CD19-CAR natural killer-cell therapy in CD20 resistant non-hodgkin lymphoma

scientific article published on 26 November 2019

Lenalidomide in non-Hodgkin lymphoma: biological perspectives and therapeutic opportunities

artículo científico publicado en 2015

Long-term outcome of individuals with pure red cell aplasia and antierythropoietin antibodies in patients treated with recombinant epoetin: a follow-up report from the Research on Adverse Drug Events and Reports (RADAR) Project

artículo científico publicado en 2005

Lymphoma Occurring During Pregnancy: Current Diagnostic and Therapeutic Approaches

artículo científico publicado en 2020

Lymphoma occurring during pregnancy: antenatal therapy, complications, and maternal survival in a multicenter analysis.

artículo científico publicado en 2013

Maintenance rituximab or observation after frontline treatment with bendamustine-rituximab for follicular lymphoma

artículo científico publicado en 2018

Management of older Hodgkin lymphoma patients

scientific article published on 01 December 2019

Microfluidic assembly of hydrogel-based immunogenic tumor spheroids for evaluation of anticancer therapies and biomarker release

artículo científico publicado en 2018

Mitochondrial-mediated apoptosis in lymphoma cells by the diterpenoid lactone andrographolide, the active component of Andrographis paniculata ⬇️

artículo científico publicado en 2010

Molecular etiology of mature T-cell non-Hodgkin's lymphomas

artículo científico publicado en 2003

Motexafin gadolinium enhances p53-Mdm2 interactions, reducing p53 and downstream targets in lymphoma cell lines.

artículo científico publicado en 2010

Motexafin gadolinium generates reactive oxygen species and induces apoptosis in sensitive and highly resistant multiple myeloma cells

artículo científico publicado en 2004

Motexafin gadolinium induces oxidative stress and apoptosis in hematologic malignancies.

artículo científico publicado en 2005

Motexafin gadolinium: a redox-active tumor selective agent for the treatment of cancer

artículo científico publicado en 2004

Multicenter Phase II Study of Sequential Brentuximab Vedotin and Doxorubicin, Vinblastine, and Dacarbazine Chemotherapy for Older Patients With Untreated Classical Hodgkin Lymphoma

article

Multicenter analysis of 80 solid organ transplantation recipients with post-transplantation lymphoproliferative disease: outcomes and prognostic factors in the modern era.

artículo científico publicado en 2010

Multiple successful desensitizations to brentuximab vedotin: a case report and literature review

artículo científico

Obesity and risk of non-Hodgkin lymphoma (United States)

scientific article published on 07 May 2007

Obinutuzumab plus CHOP is effective and has a tolerable safety profile in previously untreated, advanced diffuse large B-cell lymphoma: the phase II GATHER study

artículo científico publicado en 2018

Outcomes in adolescents and young adults with Hodgkin lymphoma treated on US cooperative group protocols: An adult intergroup (E2496) and Children's Oncology Group (COG AHOD0031) comparative analysis.

artículo científico publicado en 2017

Outcomes of CLL patients treated with sequential kinase inhibitor therapy: a real world experience.

artículo científico publicado en 2016

Oxidative stress and apoptosis: a new treatment paradigm in cancer.

artículo científico publicado en 2006

PCI-24781 induces caspase and reactive oxygen species-dependent apoptosis through NF-kappaB mechanisms and is synergistic with bortezomib in lymphoma cells

artículo científico publicado en 2009

PD-L1 expression in EBV-negative diffuse large B-cell lymphoma: clinicopathologic features and prognostic implications.

artículo científico publicado en 2016

Pancreatitis in patients treated with brentuximab vedotin: a previously unrecognized serious adverse event

artículo científico publicado en 2014

Paradoxical regulation of hypoxia inducible factor-1α (HIF-1α) by histone deacetylase inhibitor in diffuse large B-cell lymphoma

artículo científico publicado en 2013

Paraneoplastic pyoderma gangrenosum with posttransplant lymphoproliferative disorder.

artículo científico publicado en 2014

Patterns of Failure and Survival Outcomes after Total Lymphoid Irradiation and High-Dose Chemotherapy with Autologous Stem Cell Transplantation for Relapsed or Refractory Classical Hodgkin Lymphoma

scientific article published on 11 February 2019

Pemetrexed in the treatment of relapsed/refractory primary central nervous system lymphoma

scientific article published on 16 December 2011

Periodontal disease and risk of non-Hodgkin lymphoma in the Health Professionals Follow-Up Study.

artículo científico publicado en 2016

Peripheral T-cell lymphomas in a large US multicenter cohort: prognostication in the modern era including impact of frontline therapy

artículo científico publicado en 2014

Phase I/II trial of total lymphoid irradiation and high-dose chemotherapy with autologous stem-cell transplantation for relapsed and refractory Hodgkin's lymphoma.

artículo científico publicado en 2007

Post transplant lymphoproliferative disorders: risk, classification, and therapeutic recommendations.

artículo científico

Post-transplant lymphoproliferative disease (PTLD): risk factors, diagnosis, and current treatment strategies

artículo científico

Post-transplantation lymphoproliferative disorders: diagnosis, prognosis, and current approaches to therapy.

artículo científico publicado en 2010

Pre-diagnosis cigarette smoking and overall survival in non-Hodgkin lymphoma

artículo científico publicado en 2013

Primary CNS posttransplant lymphoproliferative disease (PTLD): an international report of 84 cases in the modern era.

artículo científico publicado en 2013

Primary cutaneous and systemic anaplastic large cell lymphoma: clinicopathologic aspects and therapeutic options

artículo científico publicado en 2010

Primary mediastinal large B-cell lymphoma in HIV: report of two cases

scientific article published on 28 February 2009

Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project

artículo científico publicado en 2009

Proteasomal Inhibition by Ixazomib Induces CHK1 and MYC-Dependent Cell Death in T-cell and Hodgkin Lymphoma

artículo científico publicado en 2016

Proton irradiation impacts age-driven modulations of cancer progression influenced by immune system transcriptome modifications from splenic tissue

artículo científico publicado en 2015

Pure red-cell aplasia and epoetin therapy

artículo científico publicado en 2004

Racial disparities in Hodgkin's lymphoma: a comprehensive population-based analysis.

artículo científico publicado en 2012

Radioimmunotherapy for the treatment of non-Hodgkin lymphoma: current status and future applications.

artículo científico publicado en 2010

Radioimmunotherapy in non-Hodgkin's lymphoma: trials of yttrium 90-labeled ibritumomab tiuxetan and beyond

artículo científico publicado en 2004

Reduced-dose rasburicase (recombinant xanthine oxidase) in adult cancer patients with hyperuricemia.

artículo científico publicado en 2006

Relapsed and refractory Hodgkin lymphoma: transplantation strategies and novel therapeutic options.

artículo científico publicado en 2007

Rituximab-induced late-onset neutropenia in newly diagnosed B-cell lymphoma correlates with Fc receptor FcγRIIIa 158(V/F) polymorphism.

artículo científico publicado en 2010

Role of cytotoxic therapy with hematopoietic cell transplantation in the treatment of Hodgkin lymphoma: guidelines from the American Society for Blood and Marrow Transplantation.

artículo científico

Role of hypoxia in Diffuse Large B-cell Lymphoma: Metabolic repression and selective translation of HK2 facilitates development of DLBCL.

artículo científico publicado en 2018

Select interviews from the 2011 San Antonio Breast Cancer Symposium (SABCS) and American Society of Hematology (ASH) Annual Meeting.

artículo científico publicado en 2011

Serum levels of TARC, MDC, IL-10, and soluble CD163 in Hodgkin lymphoma: a SWOG S0816 correlative study

artículo científico publicado en 2019

Stem cell transplantation for follicular lymphoma relapsed/refractory after prior rituximab: a comprehensive analysis from the NCCN lymphoma outcomes project.

artículo científico publicado en 2013

Sun exposure and non-Hodgkin lymphoma: a population-based, case-control study

artículo científico publicado en 2007

Survival Analyses and Prognosis of Plasma-Cell Myeloma and Plasmacytoma-Like Posttransplantation Lymphoproliferative Disorders

artículo científico publicado en 2016

Survival Outcomes of Younger Patients With Mantle Cell Lymphoma Treated in the Rituximab Era

scientific article published on 07 January 2019

Sustained hematologic and central nervous system remission with single-agent denileukin diftitox in refractory adult T-cell leukemia/lymphoma.

artículo científico publicado en 2007

T-cell non-Hodgkin lymphoma

artículo científico publicado en 2005

T-cell non-Hogdkin's lymphoma

artículo científico publicado en 2006

TTP/HUS occurring in a simultaneous pancreas/kidney transplant recipient after clopidogrel treatment: evidence of a nonimmunological etiology

artículo científico publicado en 2002

Targeting angiogenesis for the treatment of sarcoma

artículo científico publicado en 2006

Thalidomide- and lenalidomide-associated thromboembolism among patients with cancer.

artículo científico publicado en 2006

The Genetic Basis of Hepatosplenic T-cell Lymphoma.

artículo científico publicado en 2017

The Impact of Age and Sex in DLBCL: Systems Biology Analyses Identify Distinct Molecular Changes and Signaling Networks

artículo científico publicado en 2015

The Research on Adverse Drug Events and Reports (RADAR) project.

artículo científico publicado en 2005

The challenges of epidemiologic research in non-Hodgkin lymphoma.

artículo científico publicado en 2008

The efficacy and tolerability of adriamycin, bleomycin, vinblastine, dacarbazine and Stanford V in older Hodgkin lymphoma patients: a comprehensive analysis from the North American intergroup trial E2496

artículo científico publicado en 2013

The evolving role of response-adapted PET imaging in Hodgkin lymphoma

artículo científico publicado en 2016

The genetic landscape of mutations in Burkitt lymphoma

artículo científico publicado en 2012

The immune checkpoint molecules PD-1, PD-L1, TIM-3 and LAG-3 in diffuse large B-cell lymphoma

artículo científico publicado en 2019

The impact of race, age, and sex in follicular lymphoma: A comprehensive SEER analysis across consecutive treatment eras

artículo científico publicado en 2014

The impact of race, ethnicity, age and sex on clinical outcome in chronic lymphocytic leukemia: a comprehensive Surveillance, Epidemiology, and End Results analysis in the modern era

artículo científico publicado en 2014

The novel anti-MEK small molecule AZD6244 induces BIM-dependent and AKT-independent apoptosis in diffuse large B-cell lymphoma

artículo científico publicado en 2011

The novel expanded porphyrin, motexafin gadolinium, combined with [90Y]ibritumomab tiuxetan for relapsed/refractory non-Hodgkin's lymphoma: preclinical findings and results of a phase I trial.

artículo científico publicado en 2009

The novel organic arsenical darinaparsin induces MAPK-mediated and SHP1-dependent cell death in T-cell lymphoma and Hodgkin lymphoma cells and human xenograft models.

artículo científico publicado en 2014

The potential of arsenic trioxide in the treatment of malignant disease: past, present, and future

artículo científico publicado en 2004

The role of FDG-PET in defining prognosis of Hodgkin lymphoma for early-stage disease

artículo científico publicado en 2014

The role of FDG-PET in defining prognosis of Hodgkin lymphoma for early-stage disease.

artículo científico publicado en 2014

Time to treatment response in patients with follicular lymphoma treated with bortezomib is longer compared with other histologic subtypes

artículo científico publicado en 2010

Treatment of Hodgkin lymphoma: the past, present, and future.

artículo científico publicado en 2008

Treatment of T-cell non-Hodgkin's lymphoma.

artículo científico publicado en 2004

US Intergroup Trial of Response-Adapted Therapy for Stage III to IV Hodgkin Lymphoma Using Early Interim Fluorodeoxyglucose-Positron Emission Tomography Imaging: Southwest Oncology Group S0816.

scientific article published on 11 April 2016

University of Chicago phase II consortium trial of selumetinib (MEKi) demonstrates low tolerability and efficacy in relapsed DLBCL.

artículo científico publicado en 2017

Use of total leukocyte and platelet counts to guide stem cell apheresis in healthy allogeneic donors treated with G-CSF.

artículo científico publicado en 2005

Vaccination history and risk of non-Hodgkin lymphoma: a population-based, case-control study

artículo científico publicado en 2008

XII. Hodgkin lymphoma in older patients: challenges and opportunities to improve outcomes.

artículo científico

Yttrium-90 ibritumomab tiuxetan doses calculated to deliver up to 15 Gy to critical organs may be safely combined with high-dose BEAM and autologous transplantation in relapsed or refractory B-cell non-Hodgkin's lymphoma.

artículo científico publicado en 2009

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda